In Vitro-selected RNA Cleaving DNA Enzymes from a Combinatorial Library Are Potent Inhibitors of HIV-1 Gene Expression
Overview
Authors
Affiliations
Selective inactivation of a target gene by antisense mechanisms is an important biological tool to delineate specific functions of the gene product. Approaches mediated by ribozymes and RNA-cleaving DNA enzymes (DNA enzymes) are more attractive because of their ability to catalytically cleave the target RNA. DNA enzymes have recently gained a lot of importance because they are short DNA molecules with simple structures that are expected to be stable to the nucleases present inside a mammalian cell. We have designed a strategy to identify accessible cleavage sites in HIV-1 gag RNA from a pool of random DNA enzymes, and for isolation of DNA enzymes. A pool of random sequences (all 29 nucleotides long) that contained the earlier-identified 10-23 catalytic motif were tested for their ability to cleave the target RNA. When the pool of random DNA enzymes was targeted to cleave between any A and U nucleotides, DNA enzyme 1836 was identified. Although several DNA enzymes were identified using a pool of DNA enzymes that was completely randomized with respect to its substrate-binding properties, DNA enzyme-1810 was selected for further characterization. Both DNA enzymes showed target-specific cleavage activities in the presence of Mg(2+) only. When introduced into a mammalian cell, they showed interference with HIV-1-specific gene expression. This strategy could be applied for the selection of desired target sites in any target RNA.
A promising nucleic acid therapy drug: DNAzymes and its delivery system.
Xiao L, Zhao Y, Yang M, Luan G, Du T, Deng S Front Mol Biosci. 2023; 10:1270101.
PMID: 37753371 PMC: 10518456. DOI: 10.3389/fmolb.2023.1270101.
Zhou W, Ding J, Liu J Theranostics. 2017; 7(4):1010-1025.
PMID: 28382172 PMC: 5381262. DOI: 10.7150/thno.17736.
Deoxyribozymes and bioinformatics: complementary tools to investigate axon regeneration.
Grimpe B Cell Tissue Res. 2011; 349(1):181-200.
PMID: 22190188 PMC: 7087747. DOI: 10.1007/s00441-011-1291-6.
Ke X, Yang Y, Hong S Med Oncol. 2010; 28 Suppl 1:S326-32.
PMID: 20862567 DOI: 10.1007/s12032-010-9681-2.
Marton S, Reyes-Darias J, Sanchez-Luque F, Romero-Lopez C, Berzal-Herranz A Molecules. 2010; 15(7):4610-38.
PMID: 20657381 PMC: 6257598. DOI: 10.3390/molecules15074610.